PACIRA BIOSCIENCES, INC. Gain (Loss) on Termination of Lease
PACIRA BIOSCIENCES, INC. (PCRX) reported Gain (Loss) on Termination of Lease of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-02-26
- PACIRA BIOSCIENCES, INC. gain (loss) on termination of lease for fiscal 2025 was $0.00.
- PACIRA BIOSCIENCES, INC. gain (loss) on termination of lease for fiscal 2024 was -$2.17M.
- PACIRA BIOSCIENCES, INC. gain (loss) on termination of lease for fiscal 2023 was $0.00.
- PACIRA BIOSCIENCES, INC. gain (loss) on termination of lease for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | -$2.17M 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |